Rituximab (anti-CD20)-modified AZD-2014-encapsulated nanoparticles killing of B lymphoma cells

Tang, XL; Xie, CM; Jiang, ZY; Li, A; Cai, SY; Hou, CH; Wang, J; Liang, Y; Ma, D

Wang, J (reprint author), Anhui Univ Sci & Technol, Med Coll, Huainan, Peoples R China.; Liang, Y (reprint author), Xuzhou Med Coll, Huaian Hosp, Huaian, Peoples R China.; Liang, Y (reprint author), Huaian Second Hosp, Huaian, Peoples R China.; Ma, D (rep

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018; 46 (): 1063

Abstract

The mTOR signal pathway is often highly activated in B-cell non-Hodgkin's lymphoma (NHL) and promotes cancer progression and chemo-resistance. Therefo......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索